|
OVERVIEW
Optimal open-angle glaucoma management includes 3 main components: early diagnosis, detection of progression, and
appropriate treatment. Each of these components has its own difficulties and roadblocks. Improving performance in any
of these components, separately or in combination, would be beneficial to patients and visual outcomes.
What are the issues with each of these components? Is there room for improvement? How can we achieve better outcomes?
This activity will try to answer these questions and provide insights that may help practicing ophthalmologists deliver
better care to their patients.
Return to Top
GOAL
The educational goal of this activity is to improve the knowledge, competence, and performance of ophthalmologists in managing patients with open-angle glaucoma with emphasis on early detection, risk for progression, and patient adherence to treatment.
Return to Top
INTENDED AUDIENCE
This activity is designed for ophthalmologists in attendance at the 2009 AAO/PAAO Joint Meeting. No prerequisites required.
Return to Top
AGENDA
6:30 – 7:00 AM
Registration and Breakfast
7:00 – 7:15 AM
Conference Goals
David S. Friedman, MD, MPH, PhD (Chair)
7:15 – 7:35 AM Early Detection of Open-Angle Glaucoma
David S. Greenfield, MD
7:35 – 7:55 AM
Assessing Risk for Development
and Recognizing Progression
Christopher Girkin, MD
7:55 – 8:15 AM
Nonadherence: Causes and Solutions
David S. Friedman, MD, MPH, PhD
8:15 – 8:30 AM
Concluding Remarks
David S. Friedman, MD, MPH, PhD
Return to Top
FACULTY
David S. Friedman, MD, MPH, PhD (Chair)
Professor
Wilmer Eye Institute and Bloomberg School of Public Health
Senior Ophthalmologist, Helen Keller International
Baltimore, Maryland
David S. Greenfield, MD
Professor of Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, Florida
Christopher Girkin, MD
Professor of Ophthalmology
Department of Ophthalmology
University of Alabama at Birmingham
Callahan Eye Foundation Hospital
Birmingham, Alabama
Return to Top
LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:
- IDENTIFY strategies for early detection of open-angle glaucoma.
- IDENTIFY methods for detecting disease progression in patients with open-angle glaucoma.
- ASSESS risk and DETECT progression of open-angle glaucoma in clinical case scenarios.
- RECOGNIZE doctor-patient communication and drug-related strategies to improve adherence to glaucoma medications.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this
CME activity.
Return to Top
CME INFORMATION
Accreditation Statement —The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement — The Johns Hopkins
University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure — It is the policy of The Johns Hopkins University
School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to
the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs
or devices during their presentation(s). The Johns Hopkins University School of Medicine Office of CME
has established policies in place that will identify and resolve all conflicts of interest prior to this educational
activity. Detailed disclosures will be made in the course handout materials.
Americans with Disabilities Act (ADA) — The Johns Hopkins University School
of Medicine fully complies with the legal requirements of the ADA and the rules
and regulations thereof. Please notify us if you have any special needs.
Fee Information — There is no fee for this educational activity.
Return to Top
|
